WACKER CHEMIE AG CREATING TOMORROW`S SOLUTIONS
WACKER Virtual CMD Series: BIOSOLUTIONS and R&D
Wacker Chemie AG, June 24, 2021
Ticker: WCH
www.wacker.com
Disclaimer
The information contained in this presentation is for background purposes only and is subject to amendment, revision and updating. Certain statements and information contained in this presentation may relate to future expectations and other forward-looking statements that are based on management's current views and assumptions and involve known and unknown risks and uncertainties. In addition to statements which are forward-looking by reason of context, including without limitation, statements referring to risk limitations, operational profitability, financial strength, performance targets, profitable growth opportunities, and risk adequate pricing, other words such as "may, will, should, expects, plans, intends, anticipates, believes, estimates, predicts, or continue", "potential, future, or further", and similar expressions identify forward-looking statements. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions which could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These include, among other factors, changing business or other market conditions and the prospects for growth anticipated by the Company's management. These and other factors could adversely affect the outcome and financial effects of the plans and events described herein. Statements contained in this presentation regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any statements contained in this presentation, whether as a result of new information, future events or otherwise. In particular, you should not place undue reliance on forward-looking statements, which speak only as of the date of this presentation.
Go to www.slido.com
# CMDJune2021
© Wacker Chemie AG | 1 |
Virtual CMD Series: BIOSOLUTIONS and R&D, June 24, 2021 | |
Agenda for Today
Agenda
10:00 - 11:00 AM CEST | R&D / BIOSOLUTIONS |
Our Speakers
Christian Hartel | Tobias Ohler | Susanne | Christoph Kowitz |
CEO | CFO | Leonhartsberger | Head of R&D |
President | |||
BIOSOLUTIONS |
© Wacker Chemie AG | 2 |
Virtual CMD Series: BIOSOLUTIONS and R&D, June 24, 2021 | |
WACKER: Virtual CMD Series Roadmap
June 2020
WACKER Strategy Update - Delivering on our 5 Targets
Dec 2020
SILICONES & POLYMERS - Specialties Growth & Performance Based Substitution
Today
BIOSOLUTIONS and R&D - Accelerated Growth with Cutting-Edge Technologies
Q4 2021
ESG & POLYSILICON - Leading CO2 Abatement Technologies
Q1 2022
WACKER Strategy Update - Entering a New Phase with New Group Targets & Ambitions
© Wacker Chemie AG | 3 |
Virtual CMD Series: BIOSOLUTIONS and R&D, June 24, 2021 | |
Solid Track Record on Achieving Our 5 Targets…
5 Targets
Specialties Strategy | Strong Group NCF on |
Improves Margins | Lower Capital Intensity |
1. | CapEx - Extend Leverage |
Phase | |
2. | Grow Above Chemical |
Production | |
3. | Focus Strongly on |
Sustainability | |
4. | Sustain Attractive Margins |
19% | |
€700m | |
14% | |
€400m | |
2011-15 | 2016-20 |
39%
€340m
-4%
-€40m
2011-152016-20
Over the Cycle |
5. Generate Cash |
Chemicals EBITDA (5 year avg.) | Group NCF (5 year avg.) | |
Chemicals EBITDA margin1 | Cash conversion2 |
- Ready for the Next Step
- Chemicals = SILICONES, POLYMERS and BIOSOLUTIONS 2) Cash conversion = Net cash flow / Group EBITDA
© Wacker Chemie AG | 4 |
Virtual CMD Series: BIOSOLUTIONS and R&D, June 24, 2021 | |
Attachments
- Original document
- Permalink
Disclaimer
Wacker Chemie AG published this content on 23 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 June 2021 20:41:04 UTC.
